Wilson Castro

Wilson Castro

Auto-generated profile, based on publicly available information

Wilson Castro

Department of Biochemistry, University of Lausanne, Epalinges, Switzerland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2021 in Cancer Cell
Verified
Journal Article
Closed access
JDJaikumar Duraiswamy
Jaikumar Duraiswamy
RTRiccardo Turrini
Riccardo Turrini
AMAspram Minasyan
Aspram Minasyan
DBDavid Barras
David Barras
ICIsaac Crespo
Isaac Crespo
GCGeorge Coukos
George Coukos

21 March 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MKMarton Keszei
Marton Keszei
CDCynthia Detre
Cynthia Detre
SRSvend T. Rietdijk
Svend T. Rietdijk
PMPilar Muñoz
Pilar Muñoz
XRXavier Romero
Xavier Romero
CTCox Terhorst
Cox Terhorst
Studies of human systemic lupus erythematosus patients and of murine congenic mouse strains associate genes in a DNA segment on chromosome 1 with a genetic predisposition for this disease. The systematic analysis of lupus-prone congenic mouse strains suggests a role for two isoforms of the Ly108 receptor in the pathogenesis of the disease. In this study, we demonstrate that Ly108 is involved in the pathogenesis of lupus-related autoimmunity in mice. More importantly, we identified a third protein isoform, Ly108-H1, which is absent in two lupus-prone congenic animals. Introduction of an Ly108-H1–expressing transgene markedly diminishes T cell–dependent autoimmunity in congenic B6.Sle1b mice. Thus, an immune response–suppressing isoform of Ly108 can regulate the pathogenesis of lupus.

2 July 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
WCWilson Castro
Wilson Castro
SCSonia T. Chelbi
Sonia T. Chelbi
CNCharlène Niogret
Charlène Niogret
CRCristina Ramon-Barros
Cristina Ramon-Barros
SWSuzanne P. M. Welten
Suzanne P. M. Welten
GGGreta Guarda
Greta Guarda

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ANAndreas Neerincx
Andreas Neerincx
WCWilson Castro
Wilson Castro
GGGreta Guarda
Greta Guarda
TKThomas A. Kufer
Thomas A. Kufer
Nucleotide-binding domain and leucine-rich repeat containing receptors (NLRs) are intracellular proteins mainly involved in pathogen recognition, inflammatory responses, and cell death. Until recently, the function of the family member NLR caspase recruitment domain (CARD) containing 5 (NLRC5) has been a matter of debate. It is now clear that NLRC5 acts as a transcriptional regulator of the major-histocompatibility complex (MHC) class I. In this review we detail the development of our understanding of NLRC5 function, discussing both the accepted and the controversial aspects of NLRC5 activity. We give insight into the molecular mechanisms, and the potential implications, of NLRC5 function in health and disease.

20 April 2023 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JCJesus Corria-Osorio
Jesus Corria-Osorio
SCSantiago J. Carmona
Santiago J. Carmona
ESEvangelos Stefanidis
Evangelos Stefanidis
MAMassimo Andreatta
Massimo Andreatta
YOYaquelin Ortiz-Miranda
Yaquelin Ortiz-Miranda
GCGeorge Coukos
George Coukos
To date, no immunotherapy approaches have managed to fully overcome T-cell exhaustion, which remains a mandatory fate for chronically activated effector cells and a major therapeutic challenge. Understanding how to reprogram CD8+ tumor-infiltrating lymphocytes away from exhausted effector states remains an elusive goal. Our work provides evidence that orthogonal gene engineering of T cells to secrete an interleukin (IL)-2 variant binding the IL-2Rβγ receptor and the alarmin IL-33 reprogrammed adoptively transferred T cells to acquire a novel, synthetic effector state, which deviated from canonical exhaustion and displayed superior effector functions. These cells successfully overcame homeostatic barriers in the host and led—in the absence of lymphodepletion or exogenous cytokine support—to high levels of engraftment and tumor regression. Our work unlocks a new opportunity of rationally engineering synthetic CD8+ T-cell states endowed with the ability to avoid exhaustion and control advanced solid tumors.

10 February 2016 in Nature Communications
Verified
Journal Article
Open access
KLKristina Ludigs
Kristina Ludigs
CJCamilla Jandus
Camilla Jandus
DUDaniel T. Utzschneider
Daniel T. Utzschneider
FSFrancesco Staehli
Francesco Staehli
SBStéphanie Bessoles
Stéphanie Bessoles
GGGreta Guarda
Greta Guarda
NLRC5 is a transcriptional regulator of MHC class I (MHCI), which maintains high MHCI expression particularly in T cells. Recent evidence highlights an important NK–T-cell crosstalk, raising the question on whether NLRC5 specifically modulates this interaction. Here we show that NK cells from Nlrc5-deficient mice exhibit moderate alterations in inhibitory receptor expression and responsiveness. Interestingly, NLRC5 expression in T cells is required to protect them from NK-cell-mediated elimination upon inflammation. Using T-cell-specific Nlrc5-deficient mice, we show that NK cells surprisingly break tolerance even towards ‘self’ Nlrc5-deficient T cells under inflammatory conditions. Furthermore, during chronic LCMV infection, the total CD8+ T-cell population is severely decreased in these mice, a phenotype reverted by NK-cell depletion. These findings strongly suggest that endogenous T cells with low MHCI expression become NK-cell targets, having thus important implications for T-cell responses in naturally or therapeutically induced inflammatory conditions.